Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Bone Marrow Transplant. 2009 Aug 3;45(3):490–497. doi: 10.1038/bmt.2009.181

Table 4.

Immunohistochemical analysis of pre-transplant tumor specimens for topo-1 and other polypeptides implicated in topotecan resistance

Pt. # TTP
(months)
Topo I
intensity
MIB-1
(% +)a
p53
intensity
Bcl-2
intensity
Mcl-1
intensity
Bcl-xL
intensity
Bax
intensity
1 18.1 2 8* 0 0 2 3 3
2 28.5 3 13 3 3 1 3 3
3 5.3 2 33 3 1 1 3 3
4 8.7 3 6 2.5 0 1 3 3
5 5.9 3 45 3 0 1 2 3
8 4.3 0 40 3 0 1.5 3 3
9 7.1 0 5 0 1 1 3 3
10 11.6 0 25 3 0 1 3 3
11 5.0 2 0 3 0 1 3 3
12 21.4 2 45 3 1 3 3 3
13 2.2 0.5 0 0 1.5 3 3 3
14 13.2 2.5 90 2.5 0 0 3 3
15 13.4 2.5 43 3 0 1 3 3
16 4.3 1 0 0 0 1.5 3 3
a

Estimated percentage of cells staining positive with MIB-1 antibody. All other values represent mean staining intensity in tumor cells on a scale of 0 to 3++, with values representing the mean of intensity scores from 3 or, in some cases, 2 separate cores on the same tissue microarray.